BalanceSheet - Vanta Bioscience Ltd.
Search Company
You can view Ratios for the last 5 years.
ISIN No INE413D01011 52Wk High (Rs.) 1100 BV (Rs.) 372.65 FV (Rs.) 10.00
Bookclosure 23/09/2024 52Wk Low (Rs.) 715 EPS (Rs.) 59.17 P/E (X) 14.50
Mkt Cap. (Rs. Cr.) 855.05 P/BV (X) 2.30 Div Yield (%) 0.00 Mkt Lot 1
Standalone Consolidated
(Rs. in Crs.)
ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)30.8827.953.751.341.23
Diluted EPS (Rs.)30.8827.953.751.341.23
Cash EPS (Rs.)31.0125.683.891.501.40
Book Value[Excl.RevalReserv]/Share (Rs.)305.36273.20199.26195.53194.17
Book Value[Incl.RevalReserv]/Share (Rs.)305.36273.20199.26195.53194.17
Dividend / Share (Rs.)0.000.001.000.000.00
Revenue From Operations / Share (Rs.)307.63122.6889.0345.6156.23
PBDIT / Share (Rs.)68.4451.4021.6923.389.89
PBIT / Share (Rs.)68.2251.2721.5523.239.72
PBT / Share (Rs.)43.5634.815.031.891.78
Net Profit / Share (Rs.)30.8025.543.751.341.23
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)22.2441.8924.3651.2617.58
PBIT Margin (%)22.1741.7824.2050.9317.28
PBT Margin (%)14.1528.375.654.133.17
Net Profit Margin (%)10.0120.824.212.942.18
Return on Networth / Equity (%)10.089.351.880.680.63
Return on Capital Employeed (%)11.9012.767.117.283.60
Return On Assets (%)4.235.200.870.260.26
Long Term Debt / Equity (X)0.870.460.510.620.38
Total Debt / Equity (X)0.870.460.510.620.38
Asset Turnover Ratio (%)0.500.280.180.090.12
      
LIQUIDITY RATIOS     
      
Current Ratio (X)3.213.481.761.341.08
Quick Ratio (X)2.801.921.050.790.60
Inventory Turnover Ratio (X)3.051.130.000.000.00
Dividend Payout Ratio (NP) (%)0.003.370.000.000.00
Dividend Payout Ratio (CP) (%)0.003.360.000.000.00
Earning Retention Ratio (%)0.0096.630.000.000.00
Cash Earning Retention Ratio (%)0.0096.640.000.000.00
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)2.793.121.311.101.25
Interest Coverage Ratio (Post Tax) (%)2.262.551.231.061.15
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)1206.86798.73186.93115.9188.37
EV / Net Operating Revenue (X)3.936.532.442.951.83
EV / EBITDA (X)17.6915.5910.025.7610.39
MarketCap / Net Operating Revenue (X)3.155.951.350.840.57
Retention Ratios (%)0.0096.620.000.000.00
Price / BV (X)3.182.670.600.190.16
Price / Net Operating Revenue (X)3.155.951.350.840.57
EarningsYield0.030.030.030.030.03